Preclinical Evaluation of Telomerase-Specific Oncolytic Virotherapy for Human Bone and Soft Tissue Sarcomas
Tsuyoshi Sasaki(Okayama University Hospital), Toshiyoshi Fujiwara(Okayama University), Hiroshi Tazawa(Okayama University), Yuki Morimoto(Okayama University), Toshiyuki Kunisada(Okayama University Hospital), Shunsuke Kagawa(Okayama University Hospital), Joe Hasei(Okayama University Hospital), Shuya Yano(Kawasaki Medical School), Aki Yoshida(Okayama University), Yuuri Hashimoto(Daiichi-Sankyo (Japan)), Ryosuke Yoshida(Okayama University Hospital), Toshifumi Ozaki(Okayama University), Yasuo Urata(Okayama University Hospital), Futoshi Uno(Okayama University Hospital)
Cited by 52
Related Papers
Tumor-suppressive <i>miR-34a</i> induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells
|Proceedings of the National Academy of Sciences|2007|902
Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group
|Journal of Clinical Oncology|2003|343
Osteosarcoma of the spine
|Cancer|2002|282
Percutaneous radiofrequency ablation in osteoid osteoma
|Journal of Bone and Joint Surgery - British Volume|2001|267